PAN’s President and CEO interviewed by Pharmaceutical Commerce at Access USA/Informa PAP 2025

On January 1, 2025, two new Medicare Part D reforms went into effect as a result of the Inflation Reduction Act–an annual out-of-pocket cap on prescription medication costs and the Medicare Prescription Payment Plan.

This interview from Pharmaceutical Commerce features PAN Foundation President and CEO, Kevin L. Hagan, talking about the challenges patient assistance programs face going into 2025, including uncertainties about the impact of these Medicare reforms. Hear from Kevin, who co-chaired this year’s Access USA / Informa PAP 2025 conference.